Enhanced myeloid progenitor cell cycling and apoptosis in mice lacking the chemokine receptor, CCR2

Blood

Volumn 93, Issue 5, 1999, Pages 1524-1533

  Reid, Suzanna ^b   Ritchie, Alec ^b   Boring, Landin ^b   Gosling, Jennifa ^b   Cooper, Scott ^b   Hangoc, Giao ^b   Charo, Israel F ^b   Broxmeyer, Hal E ^a  

^a INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE; CHEMOKINE RECEPTOR; CHEMOKINE RECEPTOR CCR2; GROWTH FACTOR; STEM CELL FACTOR; UNCLASSIFIED DRUG;

ANIMAL CELL; APOPTOSIS; ARTICLE; BONE MARROW CELL; CELL CYCLE; CELL SUBPOPULATION; CELL SURVIVAL; COLONY FORMATION; CONTROLLED STUDY; FLOW CYTOMETRY; HEMATOPOIETIC STEM CELL; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROMYELOCYTE; PROTEIN EXPRESSION; SPLEEN CELL; STEM CELL; TRANSGENIC MOUSE;

EID: 0033105728     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v93.5.1524     Document Type: Article

References (65)

1. Broxmeyer HE: Hematopoietic stem cells, in Trubowitz S, David S (eds): The Human Bone Marrow. Boca Raton, FL, CRC, 1982, p 77
2. Broxmeyer HE: Granulopoiesis, in Trubowitz S, David S (eds): The Human Bone Marrow. Boca Raton, FL, CRC, 1982, p 145
3. McKenna SL, Cotter TG: Functional aspects of apoptosis in hematopoiesis and consequences of failure. Adv Cancer Res 71:121, 1997
4. Rollins BJ: Chemokines. Blood 90:909, 1997
5. Baggiolini M, Dewald B, Moser B: Human chemokines, an update. Annu Rev Immunol 15:675, 1997
6. Broxmeyer HE: Myelosuppressive cytokines and peptides, in Whetton T, Gordon T (eds): Blood Cell Biochemistry, vol 7: Hemopoietic Growth Factors. London, UK, Plenum, 1996, p 121
7. Verfaillie CM: Chemokines as inhibitors of hematopoietic progenitors. J Lab Clin Med 127:148, 1996
8. Broxmeyer HE: The hematopoietic system: Principles of therapy with hematopoietically active cytokines, in Ganser A, Hoelzer D (eds): Cytokines in the Treatment of Hematopoietic Failure. New York, NY, Marcel Dekker, 1998, p 1
9. Broxmeyer HE, Kim CH: Chemokines and hematopoiesis, in Rollins BJ (ed): Chemokines and Cancer. Clifton, NJ, Humana (in press)
10. Maze R, Sherry B, Kwon BS, Cerami A, Broxmeyer HE: Myelosuppressive effects in vivo of purified recombinant murine macrophage inflammatory protein-1 alpha. J Immunol 149:1004, 1992
11. Clements JM, Craig S, Gearing AJH, Hunter MG, Heyworth CM, Dexter TM, Lord BI: Biological and structural properties of MIP-1α expressed in yeast. Cytokine 4:76, 1992
12. Lord BI, Dexter TM, Clements JM, Hunter MA, Gearing AJH: Macrophage inflammatory protein protects multipotent hematopoietic cells from cytotoxic effects of hydroxyurea in vivo. Blood 79:2605, 1992
13. Dunlop DJ, Wright EG, Lorimore S, Graham GJ, Holyoake T, Kerr DJ, Wolpe SD, Pragnell IB: Demonstration of stem cell inhibition and myeloprotective effects of SCI/rhMIP-1α in vivo. Blood 79:2221, 1992
14. Cooper S, Mantel C, Broxmeyer HE: Myelosuppressive effects in vivo with very low dosages of monomeric recombinant murine macrophage inflammatory protein-1α. Exp Hematol 22:186, 1994
15. Daly TJ, LaRosa GJ, Dolich S, Maione TE, Cooper S, Broxmeyer HE: High activity suppression of myeloid progenitor proliferation by chimeric mutants of interleukin 8 and platelet factor 4. J Biol Chem 270:23282, 1995
16. Broxmeyer HE, Cooper S, Hague N, Benninger L, Sarris A, Cornetta K, Vadhan-Raj S, Hendrie P, Mantel C: Human chemokines: enhancement of specific activity and effects in vitro on normal and leukemic progenitors and a factor dependent cell line and in vivo in mice. Ann Hematol 71:235, 1995
17. Broxmeyer HE, Pelus LM, Hromas R, Kwon B, Youn B, Fife K, Krathwohl MD, Kim C, White JR, Hangoc G, Cooper S: Myelosuppression in vitro and in vivo by newly identified members of the cysteine cysteine (CC), CXC and C chemokine family and synergistic suppression in vivo by combinations of these chemokines. Blood 90:475a, 1997 (abstr, suppl 1, part 1)
18. Broxmeyer HE, Orazi A, Hague NL, Sledge GW Jr, Rasmussen H, Gordon MS: Myeloid progenitor cell proliferation and mobilization effects of BB10010, a genetically engineered variant of human macrophage inflammatory protein-la, in a phase I clinical trial in patients with relapsed/refractory breast cancer. Blood Cells Mol Dis 24:14, 1998
19. Graham GJ, Wright EG, Hewick R, Wolpe SD, Wilkie NM, Donaldson D, Lorimore S, Pragnell IB: Identification and characterization of an inhibitor of haemopoietic stem cell proliferation. Nature 344:442, 1990
20. Broxmeyer HE, Sherry B, Lu L, Cooper S, Oh KO, Tekamp-Olson P, Kwon BS, Cerami A: Enhancing and suppressing effects of recombinant murine macrophage inflammatory proteins on colony formation in vitro by bone marrow myeloid progenitor cells. Blood 76:1110, 1990
21. Broxmeyer HE, Sherry B, Cooper S, Lu L, Maze R, Beckmann MP, Cerami A, Ralph P: Comparative analysis of the suppressive effects of the human macrophage inflammatory protein family of cytokines (chemokines) on proliferation of human myeloid progenitor cells. J Immunol 150:3448, 1993
22. + progenitors to peripheral blood. Exp Med 185:111, 1997
23. Kim CH, Broxmeyer HE: In vitro behavior of hematopoietic progenitor cells under the influence of chemoattractants: Stromal cell-derived factor-1, steel factor and the bone marrow environment. Blood 91:100, 1998
24. Gao JL, Wynn TA, Chang Y, Lee E, Broxmeyer HE, Cooper E, Tiffany HL, Westphal H, Kwon-Chung J, Murphy PM: Impaired host defense, hematopoiesis, granulomatous inflammation and type 1/type 2 cytokine balance in mice lacking CC chemokine receptor 1. J Exp Med 185:1959, 1997
25. Kim CH, Pelus LM, White JR, Broxmeyer HE: CKβ-11/MIP-3β/ ELC, a CC chemokine, is a chemoattractant with a specificity for macrophage progenitors amongst myeloid progenitors. J Immunol 161:2580, 1998
26. Broxmeyer HE, Cooper S, Cacalano G, Hague NL, Bailish E, Moore MW: Interleukin-8 receptor is involved in negative regulation of myeloid progenitor cells in vivo: Evidence from mice lacking the murine IL-8 receptor homolog. J Exp Med 184:1825, 1996
27. Broxmeyer HE, Cooper S, Hangoc G, Gao JL, Murphy PM: Chemokine receptor CCR1 acts as a dominant receptor for MIP-1α enhancement of proliferation of mature progenitors in vitro, MIP-1α mobilization of progenitors in vivo, and MIP-1α enhancement of G-CSF induced mobilization, but not for MIP-1α suppression of immature progenitors in vitro: Effects elucidated using CCR1 knockout mice. Blood 90:571a, (abstr 2541, suppl 1, part 1)
28. Boring L, Gosling J, Chensue SW, Kunkel SL, Farese RV Jr, Broxmeyer HE, Charo IF: Impaired monocyte migration and reduced type 1 (Th1) cytokine responses in CCR2 knockout mice. J Clin Invest 100:2552, 1997
29. Cooper S, Broxmeyer HE: Measurement of interleukin-3 and other hematopoietic growth factors, such as GM-CSF, G-CSF, M-CSF, erythropoietin and the potent co-stimulating cytokines steel factor and Flt-3 ligand, in Coligan JE, Kruisbeek AM, Margulies DH, Shevach EM, Strober W, Coico R (eds): Current Protocols in Immunology. New York, NY, Wiley, 1996, p 6.4.1 (suppl 18)
30. Reid S, Cross R, Snow EC: Hoescht 3342 and merocyanine 540 staining to examine murine B cell cycle stage, viability and apoptosis. J Immunol Methods 192:43, 1996
31. Ogawa M, Matsuzaki Y, Nishikawa S, Hayashi SI, Kunisada T, Sudo T, Kina T, Nakauchi H, Nishikawa SI: Expression and function of c-kit in hematopoietic progenitor cells. J Exp Med 174:63, 1991
32. Okada S, Nakauchi H, Nagayoshi K, Nishikawa S, Nishikawa SI, Miura Y, Suda T: Enrichment and characterization of murine hematopoietic stem cells that express c-kit molecule. Blood 78:1706, 1991
33. Ikuta K, Weissman IL: Evidence that hematopoietic stem cells express mouse c-kit but do not depend on steel factor for their generation. Proc Natl Acad Sci USA 89:1502, 1992
34. low/- hematopoietic stem cells. J Immunol 156:3207, 1996
35. McEvoy L, Schlegel RA, Williamson P, DelBuono BJ: Merocyanine 540 as a flow cytometric probe of membrane lipid organization in leukocytes. J Leukoc Biol 44:337, 1988
36. Chiu L, Cherwinski H, Dunne JF: Hoechst 33342 emission analysis allows multiparamatic characterization of apoptotic lymphocytes. J Immunol Methods 189:157, 1996
37. Martin SJ, Reutelingsperger CPM, McGahan AJ, Rader JA, Van Schie RCAA, Laface DM, Green DR: Early distribution of plasma membrane phosphatidylserine is a general feature of apoptosis regardless of the initiating stimulus: Inhibition by overexpression of Bcl-2 and Abl. J Exp Med 182:1545, 1995
38. Hall SE, Savill JS, Henson PM, Haslett C: Apoptotic neutrophils are phagocytosed by fibroblasts with participation of the fibroblast vitronectin receptor and involvement of mannose/fucose specific lectin. J Immunol 153:3218, 1994
39. Dini L, Lentini A, Diez G, Rocha M, Fasca L, Serafino L, Vidai-Vanachlocha F: Phagocytosis of apoptotic bodies by liver endothe-lial cells. J Cell Sci 108:967, 1995
40. Fadok VA, Voelker DR, Campbell PA, Cohen JJ, Bratton DL, Henson PM: Exposure of phosphatidyl serine on the surface of apoptotic lymphocytes triggers specific recognition and removal by macrophages. J Immunol 148:2207, 1992
41. + human marrow cells that express low levels of kit protein are enriched for long-term marrow-engrafting cells. Blood 87:4136, 1996
42. Katayama N, Shih JP, Nishikawa SI, Tatsuokina, Clark SC, Ogawa M: Stage-specific expression of c-kit protein by murine hematopoietic progenitors. Blood 82:2353, 1993
43. Randall T, Weissman IL: Phenotypic and functional changes induced at the clonal level in hematopoietic stem cells after 5-fluorouracil treatment. Blood 89:3596, 1997
44. Nibbs RJB, Wylie SM, Yang J, Landau NR, Graham GJ: Cloning and characterization of a novel promiscuous human β-chemokine receptor D6. J Biol Chem 272:32078, 1998
45. Broxmeyer HE, Williams DE, Cooper S, Shadduck RK, Gillis S, Waheed A, Urdal DL, Bicknell DC: The comparative effects in vivo of recombinant murine interleukin-3, natural murine colony stimulating factor-1 and recombinant murine granulocyte-macrophage colony stimulating factor on myelopoiesis in mice. J Clin Invest 79:721, 1987
46. Broxmeyer HE, Williams DE, Hangoc G, Cooper S, Gillis S, Shadduck RK, Bicknell DC: Synergistic myelopoietic action in vivo of combinations of purified natural murine colony stimulating factor-1, recombinant murine interleukin-3, and recombinant murine granulocyte-macrophage colony stimulating factor administered to mice. Proc Natl Acad Sci USA 84:3871, 1987
47. Broxmeyer HE, Williams DE, Cooper S, Hangoc G, Ralph P: Recombinant human granulocyte-colony stimulating factor and recombinant human macrophage-colony stimulating factor synergise in vivo to enhance proliferation of granulocyte-macrophage, erythroid and multipotential progenitor cells in mice. J Cell Biochem 38:127, 1988
48. Herrera RE, Sah VP, Williams BO, Makela TP, Weinberg RA, Jacks T: Altered cell cycle kinetics, gene expression, and G1 restriction point regulation in Rb-deficient fibroblasts. Mol Cell Biol 16:2402, 1996
49. Quelle DE, Ashmun RA, Shurtleff SA, Kato JY, Bar-Sagi D, Roussel MF, Sherr CJ: Over expression of mouse D-type cyclins accelerates G1 phase in rodent fibroblasts. Genes Dev 7:1559, 1993
50. Jiang W, Kahn SM, Zhou P, Zhang YJ, Cacace AM, Infante AS, Doi S, Santella RM, Weinstein IB: Over expression of cyclin D1 in rat fibroblasts causes abnormalities in growth control, cell cycle progression and gene expression. Oncogene 8:3447, 1993
51. Mahmud N, Katayana N, Ohishi K, Ryugo I, Minami N, Shiku H: Stage-specific cell-cycling of hematopoietic progenitor cells. Leukemia 3:461, 1997 (suppl)
52. Necas E, Sefe L, Sulc K, Barthel E, Seidel HJ: Estimation of the extent of cell death in different stages of normal murine hematopoiesis. Stem Cells 16:107, 1998
53. Cook DN, Beck MA, Coffman TM, Kirby SL, Sheridan JF, Pragnell IB, Smithies O: Requirement of MIP-1α for an inflammatory response to viral infection. Science 269:1583, 1995
54. Hodgson GS, Bradley TR, Radley JM: The organization of hemopoietic tissue as inferred from the effects of 5-fluorouracil. Exp Hematol 10:26, 1982
55. Young JC, Varma A, Di Giusto D, Backer MP: Retention of quiescent hematopoitic cells with high proliferative potential during ex vivo stem cell culture. Blood 87:545, 1996
56. Gardner RV, Astle CM, Harrison DE: Hematopoietic precursor cell exhaustion is a cause of proliferative defects in primitive hematopoietic stem cells (PHSC) after chemotherapy. Exp Hematol 25:495, 1997
57. Siminovitch L, Till JE, McCulloch EA: Decline in colony-forming ability of marrow cells subjected to serial transplantation into irradiated mice. J Cell Comp Physiol 64:23, 1964
58. Harrison DE, Astle CM: Loss of stem cell repopulating ability upon transplantation. J Exp Med 156:1767, 1982
59. Harrison DE, Stone M, Astle CM: Effects of transplantation on the primitive immunohematopoietic stem cell. J Exp Med 172:431, 1990
60. Rosendal M, Hodgson GS, Bradley TR: Organization of haemopoietic stem cells: The generation-age hypothesis. Cell Tissue Kinet 12:17, 1979
61. Kay HEM: How many cell generations? Lancet 2:418, 1965
62. Iscove II, Nawa K: Hematopoietic stem cells expand during serial transplantation in vivo without apparent exhaustion. Curr Biol 7:805, 1997
63. Lerner C, Harrison DE: 5-Fluorouracil spares hemopoietic stem cells responsible for long-term repopulation. Exp Hematol 18:114, 1990